blue shield of california glp-1 Cross Blue to stop covering popular weight-loss drugs blue shield of california glp-1
Description
Like liraglutide, gastrointestinal symptoms were the most common side effects, though generally well-tolerated
SB: Supervision, Conceptualization, Writing review & editing
"Keurig Dr Pepper Reports Q4 and Full Year 2024 Results and Provides 2025 Outlook." PR Newswire, February 2025
report any significant changes in mood, sleep disturbance, or psychological symptoms
Side effects are generally mild and decrease over time
